Sales Ended

PERSPECTIVES IN ENTREPRENEURSHIP: From Ideation to Activation

Event Information

Share this event

Date and Time

Location

Location

Cannon Room

240 Longwood Avenue

Building C Room 114

Boston, MA 02115

View Map

Friends Who Are Going
Event description

Description

Are you a PhD, PostDoc, Medical student who has an idea, or lots of ideas and are wondering how to vet through them and how to get started? Join us for a fireside chat with Dr. Kiran Reddy and moderated by Suneel Gupta, Entrepreneur in Residence at Kleiner Perkins. Dr. Reddy will share valuable insights on what the process can look like to go from ideation to activation!

This is the second session in the new PERSPECTIVES IN ENTREPRENEURSHIP Speaker Series. The goal of this ongoing set of talks is to set the stage for would-be healthcare entrepreneurs interested in utilizing their expertise and innate skills to launch commercial ventures across the spectrum of health care, including digital health and biomedical focus areas.



The series will include:

"The Founder's Mindset featuring Suneel Gupta

April 5th 5:00 - 6:30pm TMEC 306 (Holmes)


"From Ideation to Activation" featuring Kiran Reddy

May 10th: Cannon Room

5:00 - 6:00pm - Fireside Chat with Dr. Kiran Reddy (moderated by Suneel Gupta)

6:00 - 6:30pm - Networking


"Backing Your Idea" featuring Tom Lee

June 20th: Cannon Room

5:00 - 6:30pm - Fireside Chat with Tom Lee (Founder and CEO of One Medical Group)



KIRAN REDDY



PRAXIS PRECISION MEDICINE, PRESIDENT & CEO

CLARUS VENTURES, VENTURE PARTNER

Kiran Reddy is the President & CEO of a Praxis Precision Medicines, a new biotech company focused on precision medicine in genetically defined autism and neurodevelopmental disorders. He is also a Venture Partner at Clarus Ventures where he focuses on new company formation, venture investments, and risk sharing partnerships with pharmaceutical companies. Prior to Clarus, Kiran was at Biogen as part of the Corporate Strategy leadership team where he focused on sourcing new technologies and product opportunities to support the Company's growth via acquisitions, partnerships, and equity investments. Prior to Biogen, Kiran was an Associate Partner at Third Rock Ventures. He supported and managed various portfolio companies in addition to focusing on new company formation and new investments. He was part of the founding team and interim Chief Business Officer for SAGE Therapeutics through its IPO, and co-inventor of SAGE-547 the Phase 3 program for the rare epilepsy disorder refractory status epilepticus. Kiran was part of the team that launched Foundation Medicine, and he has served as a Board Observer for Alnara pharmaceuticals, Rhythm pharmaceuticals, and PanOptica pharmaceuticals. Before Third Rock Ventures, Kiran was a management consultant at the Lewin Group within in the biotechnology and pharmaceutical practice, and advised clients on clinical development and commercial strategy. Kiran holds MD and MBA degrees from Georgetown University. He completed his internship in medicine and his neurology residency at Harvard / Massachusetts General Hospital and is a board certified neurologist. Kiran was previously a Howard Hughes science fellow, and has authored several peer-reviewed scientific papers in the field of pilepsy, neuroimmunology and neurodegenerative diseases.

Have a question for Kiran? Share it using the link below so we can answer it on May 10th!

Link: https://goo.gl/forms/DazDhovrHMaSPdjH2

Share with friends

Date and Time

Location

Cannon Room

240 Longwood Avenue

Building C Room 114

Boston, MA 02115

View Map

Save This Event

Event Saved